Hypomanic episode secondary to sibutramine in a patient with type-I bipolar disorder

Revista Brasileira de Psiquiatria

Volumn 30, Issue 4, 2008, Pages 400-401

  Da Rocha, Felipe Filardi ^a   Bamberg, Thiago Ottoni ^a   Pinto, Fernanda Curry Carneiro ^b   Gomes, Laura Mourão Guimarães ^b   Silveira, Sandreane ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE JOSÉ DO ROSÁRIO VELLANO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; FLUOXETINE; LITHIUM CARBONATE; RISPERIDONE; SIBUTRAMINE; VALPROIC ACID;

ADULT; ANAMNESIS; BIPOLAR I DISORDER; BODY MASS; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; HYPOMANIA; LABORATORY TEST; LETTER; OBESITY; REMISSION;

ADULT; APPETITE DEPRESSANTS; BIPOLAR DISORDER; CYCLOBUTANES; FEMALE; HUMANS; OBESITY;

EID: 58549111993     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462008000400018     Document Type: Letter

References (5)

1. Cordeiro Q, Vallada H. Sibutramine-induced mania episode in a bipolar patient. Int J Neuropsychopharmacol. 2002;5(3):283-4.
2. McElroy SL, Frye MA, Altshuler LL, Suppes T, Hellemann G, Black D, Mintz J, Kupka R, Nolen W, Leverich GS, Denicoff KD, Post RM, Keck PE Jr. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. Bipolar Disord. 2007;9(4):426-34.
3. Ferreira AD, Neves FS, da Rocha FF, Silva GS, Romano-Silva MA, Miranda DM, De Marco L, Correa H. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder. J Affect Disord. 2008. [Epub ahead of print]
4. Benazzi F. Organic hypomania secondary to sibutramine-citalopram interaction. J Clin Psychiatry. 2002;63(2):165.
5. Rocha FF, Bezerra BP. The metabolic syndrome and psychiatric disorders: an association that cannot be forgotten. Arq Bras Endocrinol Metabol. 2006;50(6):1138-9.